Today: 30 April 2026
Browse Category

NASDAQ:NUVB 20 November 2025 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio shares fell 4.7% to $8.05 Friday afternoon, underperforming biotech peers. UBS began coverage at Neutral with a $10 target, while RBC raised its target to $9 and reiterated Outperform. CEO David Hung is set to present at the J.P. Morgan Healthcare Conference on Jan. 13. Investors await early March results for updates on IBTROZI’s launch and pipeline spending.
9 January 2026
·
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio shares surged 49% to $7.15 on November 20, 2025, hitting a three-year high after Q3 revenue of $13.1 million nearly doubled analyst estimates. Uptake of its lung-cancer drug IBTROZI drove $7.7 million in U.S. sales and 204 new patient starts. Multiple analysts raised price targets, with the average now at $10.13. Trading volume spiked, extending a multi-day rally.
20 November 2025
·

Stock Market Today

  • Stocks to Watch: DBS, Wilmar, Sheng Siong, Starhill Global Reit, CDLHT, CDL, Lum Chang Creations
    April 29, 2026, 11:45 PM EDT. DBS posted a first-quarter net profit of S$2.93 billion, slightly above forecasts, driven by strong wealth management. The bank declared a dividend of S$0.81 per share, though its shares dipped 0.3% to S$56.56. Wilmar reported a 22.8% drop in net profit to US$265.6 million for Q1, despite a 21.9% rise in revenue to US$19.8 billion. Wilmar's shares gained 1.3% to S$3.83 ahead of results. These developments could influence trading in the Singapore market Thursday. Investors may also watch Sheng Siong, Starhill Global Reit, CDLHT, CDL, and Lum Chang Creations for news.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop